No Data
VIVA BIOTECH (01873.HK) spent 0.448 million HKD to repurchase 0.5 million shares on December 13.
Gelonghui, December 13丨VIVA BIOTECH (01873.HK) announced that on December 13, HKD 0.448 million was spent to repurchase 0.5 million shares.
VIVA BIOTECH (01873.HK) spent 0.093 million Hong Kong dollars to repurchase 0.1 million shares on December 11.
Gelonghui, December 11th丨VIVA BIOTECH (01873.HK) announced that on December 11th, it spent 0.093 million Hong Kong dollars to repurchase 0.1 million shares.
Viva Biotech Officially Establishes Boston Branch, Marking Another Milestone in Global Expansion
On December 9, viva biotech (01873.HK) spent 0.132 million Hong Kong dollars to repurchase 0.1405 million shares.
Glory Financial reported on December 9 that viva biotech (01873.HK) announced the repurchase of 0.1405 million shares at a cost of 0.132 million Hong Kong dollars on December 9.
The U.S. bioterrorism law has undergone significant changes, the CRO concept has launched a major counterattack, and WuXi AppTec is excited!
Industry pessimistic expectations may improve.
How to break through the challenges in the development of innovative drugs? The industry suggests focusing on internationalization.
① The year 2024 will be the inaugural year of large-scale authorized trade, and going abroad has become an important direction for the development of local pharmaceutical companies; ② Chinese企业品牌, clinical trial capabilities, data presentation formats, and levels of international operation still need time and practical verification.
No Data
